世界の急性腎不全治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Acute Renal Failure Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0076 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、急性腎不全治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（重曹、N-アセチルシステイン、スタチン、その他）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・急性腎不全治療の市場動向 ・企業の競争状況、市場シェア ・急性腎不全治療の種類別市場規模（重曹、N-アセチルシステイン、スタチン、その他） ・急性腎不全治療の用途別市場規模（病院、クリニック、外来手術センター） ・急性腎不全治療の北米市場規模2016-2027（アメリカ、カナダ） ・急性腎不全治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・急性腎不全治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・急性腎不全治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・急性腎不全治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Baxter、Teva Pharmaceutical、Pfizer、Novartis、Eisai Pharmaceuticals） ・結論

Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body.
Acute renal failure associated with mortality, organ dysfunctions, and development of chronic kidney diseases. It also has long term and short term issues in functional status and leads to increased healthcare expenditure. The incidence of acute renal failure is high and it most common in elderly, diabetic and obese. Etiology is also high and may be secondary to infections such as dengue, malaria, and leptospirosis. The proportion of patients receiving treatment for acute renal failure depends on the economies of the countries. Renal failure is more common in low-middle income countries followed by high-income countries. Because increasing burden of acute renal failure, professional organizations and societies are disseminating information effectively to increase awareness. American Society of Nephrology and International society of nephrology are professional organization involved in fostering education and research. Acute renal failure is common globally and imposes high health care burden. All these factors act as drivers in the robust growth of acute renal failure therapeutic.

Market Analysis and Insights: Global Acute Renal Failure Therapeutics Market
The global Acute Renal Failure Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Renal Failure Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Renal Failure Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Renal Failure Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Renal Failure Therapeutics market.

Global Acute Renal Failure Therapeutics Scope and Market Size
Acute Renal Failure Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Renal Failure Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Sodium Bicarbonates
N-Acetyl Cysteine
Statins
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Baxter
Teva Pharmaceutical
Pfizer
Novartis
Eisai Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Renal Failure Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sodium Bicarbonates
1.2.3 N-Acetyl Cysteine
1.2.4 Statins
1.2.5 Others
1.3 Market by Application
1.3.1 Global Acute Renal Failure Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Renal Failure Therapeutics Market Perspective (2016-2027)
2.2 Acute Renal Failure Therapeutics Growth Trends by Regions
2.2.1 Acute Renal Failure Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Renal Failure Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Acute Renal Failure Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Acute Renal Failure Therapeutics Industry Dynamic
2.3.1 Acute Renal Failure Therapeutics Market Trends
2.3.2 Acute Renal Failure Therapeutics Market Drivers
2.3.3 Acute Renal Failure Therapeutics Market Challenges
2.3.4 Acute Renal Failure Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Renal Failure Therapeutics Players by Revenue
3.1.1 Global Top Acute Renal Failure Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Acute Renal Failure Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Acute Renal Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Renal Failure Therapeutics Revenue
3.4 Global Acute Renal Failure Therapeutics Market Concentration Ratio
3.4.1 Global Acute Renal Failure Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Renal Failure Therapeutics Revenue in 2020
3.5 Acute Renal Failure Therapeutics Key Players Head office and Area Served
3.6 Key Players Acute Renal Failure Therapeutics Product Solution and Service
3.7 Date of Enter into Acute Renal Failure Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Renal Failure Therapeutics Breakdown Data by Type
4.1 Global Acute Renal Failure Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Acute Renal Failure Therapeutics Forecasted Market Size by Type (2022-2027)

5 Acute Renal Failure Therapeutics Breakdown Data by Application
5.1 Global Acute Renal Failure Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Acute Renal Failure Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Renal Failure Therapeutics Market Size (2016-2027)
6.2 North America Acute Renal Failure Therapeutics Market Size by Type
6.2.1 North America Acute Renal Failure Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Acute Renal Failure Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Acute Renal Failure Therapeutics Market Size by Type (2016-2027)
6.3 North America Acute Renal Failure Therapeutics Market Size by Application
6.3.1 North America Acute Renal Failure Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Acute Renal Failure Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Acute Renal Failure Therapeutics Market Size by Application (2016-2027)
6.4 North America Acute Renal Failure Therapeutics Market Size by Country
6.4.1 North America Acute Renal Failure Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Acute Renal Failure Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Acute Renal Failure Therapeutics Market Size (2016-2027)
7.2 Europe Acute Renal Failure Therapeutics Market Size by Type
7.2.1 Europe Acute Renal Failure Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Acute Renal Failure Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Acute Renal Failure Therapeutics Market Size by Type (2016-2027)
7.3 Europe Acute Renal Failure Therapeutics Market Size by Application
7.3.1 Europe Acute Renal Failure Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Acute Renal Failure Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Acute Renal Failure Therapeutics Market Size by Application (2016-2027)
7.4 Europe Acute Renal Failure Therapeutics Market Size by Country
7.4.1 Europe Acute Renal Failure Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Acute Renal Failure Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Renal Failure Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Acute Renal Failure Therapeutics Market Size by Type
8.2.1 Asia-Pacific Acute Renal Failure Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Renal Failure Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Renal Failure Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Renal Failure Therapeutics Market Size by Application
8.3.1 Asia-Pacific Acute Renal Failure Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Renal Failure Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Renal Failure Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Renal Failure Therapeutics Market Size by Region
8.4.1 Asia-Pacific Acute Renal Failure Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Renal Failure Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Renal Failure Therapeutics Market Size (2016-2027)
9.2 Latin America Acute Renal Failure Therapeutics Market Size by Type
9.2.1 Latin America Acute Renal Failure Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Acute Renal Failure Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Acute Renal Failure Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Acute Renal Failure Therapeutics Market Size by Application
9.3.1 Latin America Acute Renal Failure Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Acute Renal Failure Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Acute Renal Failure Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Acute Renal Failure Therapeutics Market Size by Country
9.4.1 Latin America Acute Renal Failure Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Acute Renal Failure Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Renal Failure Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Acute Renal Failure Therapeutics Market Size by Type
10.2.1 Middle East & Africa Acute Renal Failure Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Renal Failure Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Renal Failure Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Renal Failure Therapeutics Market Size by Application
10.3.1 Middle East & Africa Acute Renal Failure Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Renal Failure Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Renal Failure Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Renal Failure Therapeutics Market Size by Country
10.4.1 Middle East & Africa Acute Renal Failure Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Renal Failure Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Baxter
11.1.1 Baxter Company Details
11.1.2 Baxter Business Overview
11.1.3 Baxter Acute Renal Failure Therapeutics Introduction
11.1.4 Baxter Revenue in Acute Renal Failure Therapeutics Business (2016-2021)
11.1.5 Baxter Recent Development
11.2 Teva Pharmaceutical
11.2.1 Teva Pharmaceutical Company Details
11.2.2 Teva Pharmaceutical Business Overview
11.2.3 Teva Pharmaceutical Acute Renal Failure Therapeutics Introduction
11.2.4 Teva Pharmaceutical Revenue in Acute Renal Failure Therapeutics Business (2016-2021)
11.2.5 Teva Pharmaceutical Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Acute Renal Failure Therapeutics Introduction
11.3.4 Pfizer Revenue in Acute Renal Failure Therapeutics Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Acute Renal Failure Therapeutics Introduction
11.4.4 Novartis Revenue in Acute Renal Failure Therapeutics Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Eisai Pharmaceuticals
11.5.1 Eisai Pharmaceuticals Company Details
11.5.2 Eisai Pharmaceuticals Business Overview
11.5.3 Eisai Pharmaceuticals Acute Renal Failure Therapeutics Introduction
11.5.4 Eisai Pharmaceuticals Revenue in Acute Renal Failure Therapeutics Business (2016-2021)
11.5.5 Eisai Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Renal Failure Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Sodium Bicarbonates
Table 3. Key Players of N-Acetyl Cysteine
Table 4. Key Players of Statins
Table 5. Key Players of Others
Table 6. Global Acute Renal Failure Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Acute Renal Failure Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Acute Renal Failure Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Acute Renal Failure Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Acute Renal Failure Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Acute Renal Failure Therapeutics Market Share by Regions (2022-2027)
Table 12. Acute Renal Failure Therapeutics Market Trends
Table 13. Acute Renal Failure Therapeutics Market Drivers
Table 14. Acute Renal Failure Therapeutics Market Challenges
Table 15. Acute Renal Failure Therapeutics Market Restraints
Table 16. Global Acute Renal Failure Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Acute Renal Failure Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Acute Renal Failure Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Renal Failure Therapeutics as of 2020)
Table 19. Ranking of Global Top Acute Renal Failure Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Acute Renal Failure Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Acute Renal Failure Therapeutics Product Solution and Service
Table 23. Date of Enter into Acute Renal Failure Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Acute Renal Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Acute Renal Failure Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Acute Renal Failure Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Acute Renal Failure Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Acute Renal Failure Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Acute Renal Failure Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Acute Renal Failure Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Acute Renal Failure Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Acute Renal Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Acute Renal Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Acute Renal Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Acute Renal Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Acute Renal Failure Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Acute Renal Failure Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Acute Renal Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Acute Renal Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Acute Renal Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Acute Renal Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Acute Renal Failure Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Acute Renal Failure Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Acute Renal Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Acute Renal Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Acute Renal Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Acute Renal Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Acute Renal Failure Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Acute Renal Failure Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Acute Renal Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Acute Renal Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Acute Renal Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Acute Renal Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Acute Renal Failure Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Acute Renal Failure Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Acute Renal Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Acute Renal Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Acute Renal Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Acute Renal Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Acute Renal Failure Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Acute Renal Failure Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Baxter Company Details
Table 64. Baxter Business Overview
Table 65. Baxter Acute Renal Failure Therapeutics Product
Table 66. Baxter Revenue in Acute Renal Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Baxter Recent Development
Table 68. Teva Pharmaceutical Company Details
Table 69. Teva Pharmaceutical Business Overview
Table 70. Teva Pharmaceutical Acute Renal Failure Therapeutics Product
Table 71. Teva Pharmaceutical Revenue in Acute Renal Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Teva Pharmaceutical Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Acute Renal Failure Therapeutics Product
Table 76. Pfizer Revenue in Acute Renal Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Acute Renal Failure Therapeutics Product
Table 81. Novartis Revenue in Acute Renal Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. Eisai Pharmaceuticals Company Details
Table 84. Eisai Pharmaceuticals Business Overview
Table 85. Eisai Pharmaceuticals Acute Renal Failure Therapeutics Product
Table 86. Eisai Pharmaceuticals Revenue in Acute Renal Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Eisai Pharmaceuticals Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Renal Failure Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Sodium Bicarbonates Features
Figure 3. N-Acetyl Cysteine Features
Figure 4. Statins Features
Figure 5. Others Features
Figure 6. Global Acute Renal Failure Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Acute Renal Failure Therapeutics Report Years Considered
Figure 11. Global Acute Renal Failure Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Acute Renal Failure Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Acute Renal Failure Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Acute Renal Failure Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Acute Renal Failure Therapeutics Market Share by Players in 2020
Figure 16. Global Top Acute Renal Failure Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Renal Failure Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Acute Renal Failure Therapeutics Revenue in 2020
Figure 18. Global Acute Renal Failure Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Acute Renal Failure Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Acute Renal Failure Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Acute Renal Failure Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Acute Renal Failure Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Acute Renal Failure Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Acute Renal Failure Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Acute Renal Failure Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Acute Renal Failure Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Acute Renal Failure Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Acute Renal Failure Therapeutics Market Share by Region (2016-2027)
Figure 40. China Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Acute Renal Failure Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Acute Renal Failure Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Acute Renal Failure Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Acute Renal Failure Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Acute Renal Failure Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Acute Renal Failure Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Acute Renal Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Baxter Revenue Growth Rate in Acute Renal Failure Therapeutics Business (2016-2021)
Figure 60. Teva Pharmaceutical Revenue Growth Rate in Acute Renal Failure Therapeutics Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Acute Renal Failure Therapeutics Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Acute Renal Failure Therapeutics Business (2016-2021)
Figure 63. Eisai Pharmaceuticals Revenue Growth Rate in Acute Renal Failure Therapeutics Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---